Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Works in GI & liver
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) is a clinical trial sponsor. It has 1 active clinical trial with 385 planned participants, in GI & liver. Since 2021 it has completed 4 trials and stopped 0 early.
Trial track record · since 2021
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
Questions about Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 385 planned participants, in GI & liver. Since 2021 it has completed 4 trials and stopped 0 early.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company); every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-15.
Approve Suite is not affiliated with Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company).
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.